Prostate cancer is one of the most common cancers diagnosed in men, with about 310,000 new cases and 35,000 deaths occurring in the US each year.

Following former President Joseph R. Biden Jr.’s prostate cancer diagnosis, the Physicians Committee for Responsible Medicine, a nonprofit with 17,000 doctor members, is sharing resources for people looking for information on nutrition’s role in reducing the risk of prostate cancer and its progression when diagnosed.

Scientists see a worrying rise in late-stage prostate cancer diagnoses. Experts say prostate cancer screening, once seen as controversial, is beneficial.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.

Prostate cancer is one of the most common types of cancer in the U.S., and often treatable. One urologist says Biden has good options ahead — largely thanks to recent advances in research.

Proton therapy may reduce urinary, bowel and sexual side effects in prostate cancer by minimizing radiation exposure to healthy tissue, per Dr. Curtiland Deville Jr.

A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study suggests.